Skip to main content

Gerard Marti Aguasca

Institutions of which they are part

Cardiovascular Diseases
Vall Hebron Institut de Recerca

Gerard Marti Aguasca

Institutions of which they are part

Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Antiagregación en infarto con elevación del ST revascularizado con stent: Efectividad y variabilidad de la práctica clínica. Subproyecto 1

IP: Ignacio Ferreira González
Collaborators: Aida Ribera Sole, Gerard Marti Aguasca, Jordi Bañeras Rius, Bruno García del Blanco
Funding agency: Instituto de Salud Carlos III
Funding: 80465
Reference: PI13/00399
Duration: 01/01/2014 - 30/06/2018

Red Cardiovascular

IP: -
Collaborators: Jorge Guillermo Romero Farina, José Antonio Barrabés Riu, Jose Fernando Rodríguez Palomares, Laura Gutierrez García-Moreno, Antonia Sambola Ayala, Nuria Rivas Gandara, Jordi Perez Rodon, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Joan Castell Conesa, Josep Pinar Sopena, Teresa González Alujas, Gisela Teixido Tura, Antonia Pijuan Domenech, Enric Domingo Ribas, Gemma Cuberas Borros, Rosa María Lidón Corbi, Francesc Xavier Armengol Castells, Vicente Serra García, Gerard Marti Aguasca, Neus Bellera Gotarda, Imanol Otaegui Irurueta, Ignasi Barba Vert, Jordi Bañeras Rius, Bruno García del Blanco, Pilar Tornos Mas, Elisabet Miro Casas, Marisol Ruiz Meana, Mireia Andres Villarreal, Javier Inserte Igual, Red Cardiovascular, Laura Dos Subirá, Maria Nazarena Pizzi
Funding agency: Instituto de Salud Carlos III
Funding: 668059.76
Reference: RD12/0042/0021
Duration: 01/01/2013 - 30/06/2017

Eficacia y seguridad de la doble antiagregación comparada con la combinación de anticoagulación oral+doble antiagregación en pacientes con fibrilación auricular de bajo-moderado riesgo sometidos a la implantación de un stent coronario

IP: Antonia Sambola Ayala
Collaborators: Gerard Marti Aguasca, Bruno García del Blanco, Pilar Tornos Mas
Funding agency: Ministerio Sanidad
Funding: 64900
Reference: EC11-473
Duration: 01/01/2012 - 31/12/2014

Características inmunohistoquímicas y moleculares del trombo resistente a la fibrinolisis

IP: Antonia Sambola Ayala
Collaborators: Gerard Marti Aguasca, Neus Bellera Gotarda, Imanol Otaegui Irurueta
Funding agency: Instituto de Salud Carlos III
Funding: 57475
Reference: PI09/01014
Duration: 01/01/2010 - 30/06/2014

Related news

A study led by the Vall d'Hebron Research Institute (VHIR) demonstrates the causal role of air pollution in ventricular arrhythmias and identifies a possible therapeutic strategy based on antioxidants.

The grants, amounting to more than €533,000 for VHIR, will allow clinical duties to be partially released over three years to promote strategic research projects in obesity, respiratory diseases, aortic pathology and metabolic fatty liver disease.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Related professionals

Natàlia Comes Fernández

Natàlia Comes Fernández

Research technician
Transfusional Medicine
Read more
Adrià  Tomé Cabello

Adrià Tomé Cabello

Technological Infrastructure Unit
Digital Transformation Directorate
Read more
Luisa Maria Martinez Sánchez

Luisa Maria Martinez Sánchez

Research assistant
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Francisco Javier  Ramos  Gómez

Francisco Javier Ramos Gómez

Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.